Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-04 Purchase | 2023-05-08 5:22 pm | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,460,932 | $2.797 | $4,086,235 | 1,902,937 (Indirect) | View |
| 2023-04-28 Purchase | 2023-05-02 9:34 pm | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,405,168 | $2.6146 | $3,673,901 | 1,328,967 (Indirect) | View |
| 2023-04-13 Sale | 2023-04-17 5:28 pm | Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Capital GP VII LLC 10% Owner | 68,481 | $1.8729 | $128,257 | 2,417,787 (Indirect) | View |
| 2023-04-10 Sale | 2023-04-12 6:44 pm | Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Capital GP VII LLC 10% Owner | 67,537 | $1.7969 | $121,357 | 2,464,234 (Indirect) | View |
| 2023-04-05 Sale | 2023-04-07 4:42 pm | Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Capital GP VII LLC 10% Owner | 102,630 | $2.163 | $221,994 | 2,510,041 (Indirect) | View |
| 2022-12-23 Purchase | 2022-12-28 5:57 pm | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC Director 10% Owner | 137,931 | $7.25 | $1,000,000 | 7,619,135 (Indirect) | View |
| 2022-11-07 Purchase | 2022-11-09 4:25 pm | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 192,000 | $5.21 | $1,000,320 | 17,233,668 (Indirect) | View |
| 2022-09-19 Purchase | 2022-09-21 6:00 pm | Third Harmonic Bio Inc. | THRD | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 300,000 | $17 | $5,100,000 | 5,779,071 (Indirect) | View |
| 2022-08-16 Purchase | 2022-08-18 5:00 pm | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC Director 10% Owner | 3,690,000 | $2.42 | $8,929,800 | 1,072,400 (Indirect) | View |
| 2022-06-24 Sale | 2022-06-28 4:29 pm | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner | 341,971 | $21.31 | $7,287,402 | 415,142 (Indirect) | View |
| 2022-05-03 Purchase | 2022-05-05 5:23 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 525,000 | $1.9358 | $1,016,285 | 6,841,423 (Indirect) | View |
| 2022-01-20 Purchase(A) | 2022-05-05 5:11 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 50,800 | $5 | $254,000 | 6,316,423 (Indirect) | View |
| 2022-04-06 Sale | 2022-04-08 6:06 pm | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner | 878,200 | $20.68 | $18,163,608 | 451,086 (Indirect) | View |
| 2022-02-11 Purchase | 2022-02-15 9:42 pm | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director | 195,700 | $10.17 | $1,989,446 | 4,043,629 (Indirect) | View |
| 2022-01-20 Purchase | 2022-01-24 4:44 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 369,100 | $5.42 | $2,000,522 | 6,634,723 (Indirect) | View |
| 2022-01-19 Purchase | 2022-01-21 7:18 pm | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 158,417 | $9.9656 | $1,578,717 | 17,041,802 (Indirect) | View |
| 2022-01-14 Purchase | 2022-01-20 6:03 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 168,300 | $5.3785 | $905,205 | 6,265,623 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 7:37 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 150,000 | $5.6072 | $841,082 | 6,097,323 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 7:18 pm | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 44,717 | $9.9012 | $442,750 | 16,883,385 (Indirect) | View |
| 2021-12-16 Sale | 2021-12-17 5:13 pm | Janux Therapeutics Inc. | JANX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director | 393,300 | $19.07 | $7,500,231 | 245,898 (Indirect) | View |
| 2021-10-12 Purchase | 2021-10-14 5:00 pm | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 625,000 | $16 | $10,000,000 | 499,150 (Indirect) | View |
| 2021-09-03 Sale | 2021-09-08 6:18 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 8,084 | $33.99 | $274,794 | 96,190 (Indirect) | View |
| 2021-08-31 Sale | 2021-09-02 8:27 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 37,864 | $34.08 | $1,290,550 | 96,428 (Indirect) | View |
| 2021-08-26 Sale | 2021-08-30 6:37 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 18,073 | $34.07 | $615,748 | 97,542 (Indirect) | View |
| 2021-08-23 Sale | 2021-08-25 8:43 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 18,215 | $34.17 | $622,426 | 98,074 (Indirect) | View |
| 2021-08-17 Sale | 2021-08-19 8:55 pm | Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director | 20,328 | $34.1 | $693,210 | 98,610 (Indirect) | View |
| 2021-07-16 Purchase(A) | 2021-07-23 5:30 pm | IMARA Inc. | IMRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 1,666,666 | $6 | $9,999,996 | 4,199,068 (Indirect) | View |
| 2021-07-16 Purchase | 2021-07-16 4:27 pm | IMARA Inc. | IMRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,666,666 | $6 | $9,999,996 | 4,199,068 (Indirect) | View |
| 2021-02-09 Purchase | 2021-02-09 3:09 pm | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner | 475,000 | $17 | $8,075,000 | 2,274,723 (Indirect) | View |
| 2020-12-02 Purchase | 2020-12-04 6:11 pm | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director 10% Owner | 750,000 | $20 | $15,000,000 | 450,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-17 Exercise | 2023-05-19 4:19 pm | N/A 2032-06-01 | Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 2,125 | $0 | 8,951,463 (Indirect) | View |
| 2023-05-17 Exercise | 2023-05-19 4:19 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 2,125 | $4.28 | 8,951,463 (Indirect) | View |
| 2023-02-23 Option Award | 2023-02-27 8:30 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 7,899,572 | $0 | 288,114 (Indirect) | View |
| 2023-02-17 Option Award | 2023-02-23 2:16 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 550,000 | $0 | 4,593,629 (Indirect) | View |
| 2022-09-19 Conversion | 2022-09-21 6:00 pm | N/A N/A | Third Harmonic Bio Inc. | THRD | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 17,856,293 | $0 | 5,779,071 (Indirect) | View |
Ownership | 2022-09-14 6:11 pm | N/A N/A | Third Harmonic Bio Inc. | THRD | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 0 | $0 | 5,479,071 (Indirect) | View |
| 2022-07-01 Disposition | 2022-07-01 4:50 pm | 2019-11-13 2024-11-13 | Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC OrbiMed Capital GP VII LLC Director 10% Owner | 1,477,124 | $0 | 0 (Indirect) | View |
| 2022-07-01 Disposition | 2022-07-01 4:50 pm | N/A N/A | Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC OrbiMed Capital GP VII LLC Director 10% Owner | 1,738,066 | $55 | 0 (Indirect) | View |
| 2022-01-26 Exercise | 2022-01-28 9:22 pm | 2020-01-22 N/A | Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner | 487,450 | $0 | 226,704 (Indirect) | View |
| 2022-01-26 Exercise | 2022-01-28 9:22 pm | N/A N/A | Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner | 431,206 | $13.2 | 226,704 (Indirect) | View |
| 2021-10-12 Conversion | 2021-10-14 5:00 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 31,990,686 | $0 | 499,150 (Indirect) | View |
Ownership | 2021-10-06 7:00 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 0 | $0 | 16,213,668 (Indirect) | View |
| 2021-02-09 Conversion | 2021-02-09 3:09 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner | 6,632,408 | $0 | 2,274,723 (Indirect) | View |
Ownership | 2021-02-04 5:07 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner | 0 | $0 | 3,316,204 (Indirect) | View |
| 2020-12-07 Conversion | 2020-12-09 4:24 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 3,240,882 | $0 | 534,599 (Indirect) | View |
Ownership | 2020-12-02 9:07 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 0 | $0 | 3,097,929 (Indirect) | View |